1. Home
  2. CCTG vs CVKD Comparison

CCTG vs CVKD Comparison

Compare CCTG & CVKD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CCSC Technology International Holdings Limited

CCTG

CCSC Technology International Holdings Limited

HOLD

Current Price

$0.13

Market Cap

25.7M

Sector

N/A

ML Signal

HOLD

Logo Cadrenal Therapeutics Inc.

CVKD

Cadrenal Therapeutics Inc.

HOLD

Current Price

$7.41

Market Cap

20.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCTG
CVKD
Founded
1993
2022
Country
Hong Kong
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.7M
20.7M
IPO Year
2024
2023

Fundamental Metrics

Financial Performance
Metric
CCTG
CVKD
Price
$0.13
$7.41
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$32.00
AVG Volume (30 Days)
618.1K
81.3K
Earning Date
12-23-2025
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$16,878,618.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
2.52
N/A
52 Week Low
$0.12
$6.75
52 Week High
$2.61
$22.90

Technical Indicators

Market Signals
Indicator
CCTG
CVKD
Relative Strength Index (RSI) 28.67 37.10
Support Level $0.12 $6.75
Resistance Level $0.21 $7.75
Average True Range (ATR) 0.03 0.96
MACD 0.02 -0.18
Stochastic Oscillator 9.60 12.87

Price Performance

Historical Comparison
CCTG
CVKD

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas, Asia, and Others.

About CVKD Cadrenal Therapeutics Inc.

Cadrenal Therapeutics Inc is developing tecarfarin, its drug candidate, for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) designed to prevent heart attacks, strokes, and deaths due to blood clots in patients with rare cardiovascular conditions requiring chronic anticoagulation.

Share on Social Networks: